Ardsley Advisory Partners’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Ardsley Advisory Partners’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,537	Closed	-$178K	–	180
2016 Q3	$178K	Sell	1,537 -2,526	-62%	-$246K	0.03%	140
2016 Q2	$322K	Sell	4,063 -1,562	-28%	-$135K	0.06%	104
2016 Q1	$428K	Sell	5,625 -625	-10%	-$39.7K	0.07%	82
2015 Q4	$560K	Buy	6,250 +625	+11%	+$60K	0.07%	74
2015 Q3	$630K	Hold	5,625	–	–	0.15%	78
2015 Q2	$584K	Buy	5,625 +625	+13%	+$64.7K	0.07%	103
2015 Q1	$546K	Buy	5,000 +625	+14%	+$64K	0.08%	121
2014 Q4	$398K	Buy	+4,375	New	+$373K	0.06%	134

Other funds holding PLXP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Middleton & Co Boston, Massachusetts $877M AUM 15.2% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ardsley Advisory Partners's PLXP Position: Q4 2016 in Review

Ardsley Advisory Partners sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2016, closing a stake of 1,537 shares — an estimated $178K sold.

Ardsley Advisory Partners first reported a position in PLXP in Q4 2014 and held it in 8 quarters. The position peaked at $630K in Q3 2015. 19 funds tracked by Wall St. Rank hold PLXP as of Q4 2016.

Ardsley Advisory Partners reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Ardsley Advisory Partners sold 1,537 PLx Pharma Inc. Common Stock shares in Q4 2016, an estimated $178K.
Ardsley Advisory Partners first reported a position in PLx Pharma Inc. Common Stock in Q4 2014 and held it in 8 quarters.
Ardsley Advisory Partners's PLx Pharma Inc. Common Stock position peaked at $630K in Q3 2015.
19 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2016.

Based on Ardsley Advisory Partners's 13F filing for Q4 2016, filed 14 Feb 2017.